Comment on prostate cancer screening from the ECC 2013 Scientific Co-Chair

Comment on primary site tumours from the ECC 2013 Scientific Co-Chair

Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer

Research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

ICON6 phase III trial shows cediranib improves survival in recurrent ovarian cancer

Advances in CLL from iwCLL 2013

Overview of upcoming trials and possibility of new treatment approaches in CLL

Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair

Identifying disease-causing mechanisms in cancers with unknown primary site improves treatment and survival

Prostate-specific antigen test 'does more harm than good'

Results for new antibody drug in non-small cell lung cancer

Prostate-specific antigen test 'does more harm than good'